WRPWM
ABBV icon

Werba Rubin Papier Wealth Management’s AbbVie ABBV Stock Holding History

Werba Rubin Papier Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
4,226
+432
+11% +$92.9K 0.13% 92
2026
Q1 		$825K Buy
3,794
+743
+24% +$165K 0.11% 103
2025
Q4 		$697K Buy
3,051
+302
+11% +$68.8K 0.19% 84
2025
Q3 		$637K Sell
2,749
-8
-0.3% -$1.63K 0.1% 105
2025
Q2 		$512K Buy
2,757
+665
+32% +$124K 0.1% 111
2025
Q1 		$438K Buy
2,092
+149
+8% +$29K 0.1% 110
2024
Q4 		$345K Sell
1,943
-108
-5% -$19.9K 0.08% 125
2024
Q3 		$405K Buy
2,051
+98
+5% +$18.3K 0.1% 114
2024
Q2 		$335K Sell
1,953
-400
-17% -$66.3K 0.09% 115
2024
Q1 		$428K Buy
2,353
+42
+2% +$7.24K 0.12% 85
2023
Q4 		$358K Sell
2,311
-18
-0.8% -$2.62K 0.12% 72
2023
Q3 		$347K Sell
2,329
-14
-0.6% -$2.06K 0.12% 79
2023
Q2 		$316K Sell
2,343
-75
-3% -$11K 0.11% 80
2023
Q1 		$385K Buy
2,418
+4
+0.2% +$612 0.15% 66
2022
Q4 		$390K Buy
+2,414
New +$370K 0.16% 62

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Werba Rubin Papier Wealth Management's ABBV Position: Q2 2026 in Review

Werba Rubin Papier Wealth Management increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $92.9K and bringing the position to 4,226 shares worth $1.06M. The position accounts for 0.13% of the portfolio, ranked #92.

Werba Rubin Papier Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Werba Rubin Papier Wealth Management held 4,226 shares of AbbVie worth $1.06M as of Q2 2026.
  • Werba Rubin Papier Wealth Management bought 432 AbbVie shares in Q2 2026, an estimated $92.9K.
  • AbbVie made up 0.13% of Werba Rubin Papier Wealth Management's portfolio in Q2 2026, its #92 holding.
  • Werba Rubin Papier Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Werba Rubin Papier Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.